194 related articles for article (PubMed ID: 36296713)
21. Novel Planar Pt(II) Cyclometallated Cytotoxic Complexes with G-Quadruplex Stabilisation and Luminescent Properties.
McGhie BS; Sakoff J; Gilbert J; Gordon CP; Aldrich-Wright JR
Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142379
[TBL] [Abstract][Full Text] [Related]
22. Molecular, cellular and pharmacological effects of platinum(II) diiodido complexes containing 9-deazahypoxanthine derivatives: A group of broad-spectrum anticancer active agents.
Vančo J; Trávníček Z; Křikavová R; Gáliková J; Dvořák Z; Chalupová M
J Photochem Photobiol B; 2017 Aug; 173():423-433. PubMed ID: 28662469
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, characterisation and influence of lipophilicity on cellular accumulation and cytotoxicity of unconventional platinum(iv) prodrugs as potent anticancer agents.
Deo KM; Sakoff J; Gilbert J; Zhang Y; Aldrich Wright JR
Dalton Trans; 2019 Nov; 48(46):17228-17240. PubMed ID: 31728483
[TBL] [Abstract][Full Text] [Related]
24. 2,3-Dihydroquinazolin-4(1
O'Brien NS; Gilbert J; McCluskey A; Sakoff JA
RSC Med Chem; 2024 May; 15(5):1686-1708. PubMed ID: 38784470
[TBL] [Abstract][Full Text] [Related]
25. 3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety.
Sun J; Ambrus JI; Baker JR; Russell CC; Cossar PJ; Sakoff JA; Scarlett CJ; McCluskey A
Bioorg Med Chem Lett; 2022 Apr; 61():128591. PubMed ID: 35114371
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and in vitro and in vivo antitumor activity of a series of trans platinum antitumor complexes.
Kelland LR; Barnard CF; Evans IG; Murrer BA; Theobald BR; Wyer SB; Goddard PM; Jones M; Valenti M; Bryant A
J Med Chem; 1995 Aug; 38(16):3016-24. PubMed ID: 7636864
[TBL] [Abstract][Full Text] [Related]
27. A novel trans-platinum coordination complex possessing in vitro and in vivo antitumor activity.
Kelland LR; Barnard CF; Mellish KJ; Jones M; Goddard PM; Valenti M; Bryant A; Murrer BA; Harrap KR
Cancer Res; 1994 Nov; 54(21):5618-22. PubMed ID: 7923207
[TBL] [Abstract][Full Text] [Related]
28. The cellular distribution and oxidation state of platinum(II) and platinum(IV) antitumour complexes in cancer cells.
Hall MD; Dillon CT; Zhang M; Beale P; Cai Z; Lai B; Stampfl AP; Hambley TW
J Biol Inorg Chem; 2003 Sep; 8(7):726-32. PubMed ID: 12884089
[TBL] [Abstract][Full Text] [Related]
29. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.
Kelland LR; Murrer BA; Abel G; Giandomenico CM; Mistry P; Harrap KR
Cancer Res; 1992 Feb; 52(4):822-8. PubMed ID: 1737343
[TBL] [Abstract][Full Text] [Related]
30. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
[TBL] [Abstract][Full Text] [Related]
32. Dinuclear platinum anticancer complexes with fluorescent N,N'-bis(aminoalkyl)-1,4-diaminoanthraquinones: cellular processing in two cisplatin-resistant cell lines reflects the differences in their resistance profiles.
Kalayda GV; Jansen BA; Wielaard P; Tanke HJ; Reedijk J
J Biol Inorg Chem; 2005 May; 10(3):305-15. PubMed ID: 15824924
[TBL] [Abstract][Full Text] [Related]
33. Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.
Hoffmeister BR; Adib-Razavi MS; Jakupec MA; Galanski M; Keppler BK
Chem Biodivers; 2012 Sep; 9(9):1840-8. PubMed ID: 22976974
[TBL] [Abstract][Full Text] [Related]
34. Pt-Fe ferrocenyl compounds with hydroxyquinoline ligands show selective cytotoxicity on highly proliferative cells.
Rivas F; Medeiros A; Comini M; Suescun L; Rodríguez Arce E; Martins M; Pinheiro T; Marques F; Gambino D
J Inorg Biochem; 2019 Oct; 199():110779. PubMed ID: 31351379
[TBL] [Abstract][Full Text] [Related]
35. Cisplatin-cyclooxygenase inhibitor conjugates, free and immobilised in mesoporous silica SBA-15, prove highly potent against triple-negative MDA-MB-468 breast cancer cell line.
Predarska I; Saoud M; Morgan I; Eichhorn T; Kaluđerović GN; Hey-Hawkins E
Dalton Trans; 2022 Jan; 51(3):857-869. PubMed ID: 34877948
[TBL] [Abstract][Full Text] [Related]
36. Non-DNA-binding platinum anticancer agents: Cytotoxic activities of platinum-phosphato complexes towards human ovarian cancer cells.
Bose RN; Maurmann L; Mishur RJ; Yasui L; Gupta S; Grayburn WS; Hofstetter H; Salley T
Proc Natl Acad Sci U S A; 2008 Nov; 105(47):18314-9. PubMed ID: 19020081
[TBL] [Abstract][Full Text] [Related]
37. Cellular accumulation, lipophilicity and photocytotoxicity of diazido platinum(IV) anticancer complexes.
Pizarro AM; McQuitty RJ; Mackay FS; Zhao Y; Woods JA; Sadler PJ
ChemMedChem; 2014 Jun; 9(6):1169-75. PubMed ID: 24840112
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and characterization of thiocarbonato-linked platinum(IV) complexes.
Barth MC; Lange S; Häfner N; Ueberschaar N; Görls H; Runnebaum IB; Weigand W
Dalton Trans; 2022 Apr; 51(14):5567-5576. PubMed ID: 35311885
[TBL] [Abstract][Full Text] [Related]
39. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
40. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
Sharp SY; Rogers PM; Kelland LR
Clin Cancer Res; 1995 Sep; 1(9):981-9. PubMed ID: 9816070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
